MUNARI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 1.646
EU - Europa 441
AS - Asia 286
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 2.377
Nazione #
US - Stati Uniti d'America 1.642
HK - Hong Kong 175
UA - Ucraina 120
IE - Irlanda 84
SG - Singapore 83
FI - Finlandia 78
DE - Germania 72
GB - Regno Unito 38
CN - Cina 23
BE - Belgio 15
IT - Italia 11
CZ - Repubblica Ceca 5
RU - Federazione Russa 5
CA - Canada 4
SE - Svezia 4
NL - Olanda 3
AP - ???statistics.table.value.countryCode.AP??? 2
CH - Svizzera 2
FR - Francia 2
PK - Pakistan 2
AU - Australia 1
GR - Grecia 1
IN - India 1
JP - Giappone 1
MU - Mauritius 1
RS - Serbia 1
TR - Turchia 1
Totale 2.377
Città #
Fairfield 320
Hong Kong 175
Woodbridge 157
Princeton 140
Seattle 134
Ashburn 128
Wilmington 124
Houston 108
Cambridge 103
Jacksonville 100
Dublin 78
Helsinki 78
New York 68
Ann Arbor 57
Singapore 54
San Diego 30
Des Moines 28
Shanghai 20
Chandler 18
Menlo Park 16
Brussels 15
London 13
Brno 5
Chiswick 5
Los Angeles 5
Norwalk 5
Wandsworth 5
Beijing 3
Kilburn 3
Milan 3
St Petersburg 3
Vancouver 3
Würzburg 3
Acton 2
Ebikon 2
Hounslow 2
Karachi 2
New Bedfont 2
Nijmegen 2
Paris 2
Rome 2
Bari 1
Belgrade 1
Chicago 1
Falkenstein 1
Genoa 1
Kocaeli 1
Moscow 1
Negrar 1
North Bergen 1
Perm 1
Piraeus 1
Prescot 1
Pune 1
Queens 1
Ronkonkoma 1
Southwark 1
Sydney 1
Torino 1
Toronto 1
Verona 1
Totale 2.043
Nome #
Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors 87
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma 82
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 61
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 57
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma 54
⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer 53
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases 52
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 52
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 51
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 50
Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases 46
Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection 46
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines 45
MicroRNA expression profiling of Xp11 renal cell carcinoma 45
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 44
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 44
The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases 43
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 42
Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma 41
ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder 39
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine 39
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 38
Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma 38
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 38
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 37
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine 34
Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms 34
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 34
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 34
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins 33
Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy 33
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma 33
Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas 31
PD-L1 expression heterogeneity in non-small cell lung cancer: defining criteria for harmonization between biopsies and whole sections 31
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability 31
Non-small cell lung cancer: land of conquest for immunotherapy 30
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 30
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 30
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays 30
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies 30
Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression 28
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes 27
Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases 27
Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua 26
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 26
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome 26
Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 25
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists 25
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 24
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 24
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? 24
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 23
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 22
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 21
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 20
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation 19
Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors 19
Wilms’ tumor primary cells display potent immunoregulatory properties on nk cells and macrophages 18
PD-1/pd-l1 in cancer: Pathophysiological, diagnostic and therapeutic aspects 17
Challenges facing pathologists evaluating PD-L1 in head & neck squamous cell carcinoma 17
Artificial intelligence applications for pre-implantation kidney biopsy pathology practice: a systematic review 16
Characterization of human NK cell-derived exosomes: Role of DNAM1 receptor in exosome-mediated cytotoxicity against tumor 16
Pediatric tumors-mediated inhibitory effect on nk cells: The case of neuroblastoma and Wilms’ tumors 16
Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy 15
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 14
Exploiting Human NK Cells in Tumor Therapy 14
PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy 14
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 13
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 13
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 13
Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer 12
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor 12
PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation 12
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 11
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 11
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells 10
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 10
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 10
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy 10
Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword? 10
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity 9
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 9
The immune checkpoint PD-1 in natural killer cells: Expression, function and targeting in tumour immunotherapy 9
Artificial intelligence in head and neck cancer diagnosis 8
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers 7
Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review 7
Technical and Diagnostic Issues in Whole Slide Imaging Published Validation Studies 5
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 3
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 3
Totale 2.472
Categoria #
all - tutte 28.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.831


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.259 0 0 435 104 150 56 20 123 66 159 50 96
2021/2022398 9 44 11 41 4 7 9 56 84 29 34 70
2022/2023263 81 0 6 2 5 89 6 17 32 2 13 10
2023/2024539 17 14 12 96 14 70 11 27 181 2 4 91
2024/202513 4 9 0 0 0 0 0 0 0 0 0 0
Totale 2.472